Literature DB >> 17649446

The Use of Gallamycin for Controlling Infectious Atrophic Rhinitis in Bacon Pigs.

M A Macdonald.   

Abstract

The use of Gallamycin to control nasal deterioration and permit increased growth rates in bacon type pigs was studied. Litters were randomly divided according to sex into treatment and control groups. Animals were treated by injection with 2.5 mgm of Gallamycin per pound liveweight at weekly intervals commencing during the first through the fifth week of age. Treatments ceased during the eighth week of age. Gallamycin treatment did not reduce significantly the percentage of nasal turbinate degeneration nor increase the rate of gain per day of treatment compared with control animals within litters. Possible explanations of results obtained are hypothesized.

Entities:  

Year:  1963        PMID: 17649446      PMCID: PMC1583665     

Source DB:  PubMed          Journal:  Can J Comp Med Vet Sci        ISSN: 0316-5957


  5 in total

1.  Atrophic rhinitis. VII. A study of the economic effect in a swine herd.

Authors:  F L EARL; R D SHUMAN
Journal:  J Am Vet Med Assoc       Date:  1956-09-01       Impact factor: 1.936

2.  Rhinitis of Swine: I. Chronic Atrophic Rhinitis and Congenital Deformity of the Skull.

Authors:  R C Duthie
Journal:  Can J Comp Med Vet Sci       Date:  1947-09

3.  Rhinitis Of Swine IX. Further Studies On Aetiological Agents.

Authors:  R Gwatkin; L Dzenis; A S Greig; C Grinewitsch
Journal:  Can J Comp Med Vet Sci       Date:  1954-10

4.  Relationship of atrophic rhinitis and virus pig pneumonia to growth rate in swine.

Authors:  G A YOUNG; J D CALDWELL; N R UNDERDAHL
Journal:  J Am Vet Med Assoc       Date:  1959-03-01       Impact factor: 1.936

5.  Rhinitis of Swine: III. Transmission to Baby Pigs.

Authors:  R Gwatkin; P J Plummer; J L Byrne; R V Walker
Journal:  Can J Comp Med Vet Sci       Date:  1949-01
  5 in total
  1 in total

Review 1.  Infectious porcine atrophic rhinitis: a review.

Authors:  H G Pearce; C K Roe
Journal:  Can Vet J       Date:  1966-11       Impact factor: 1.008

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.